BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28040451)

  • 21. Structural and functional characterization of the USP11 deubiquitinating enzyme, which interacts with the RanGTP-associated protein RanBPM.
    Ideguchi H; Ueda A; Tanaka M; Yang J; Tsuji T; Ohno S; Hagiwara E; Aoki A; Ishigatsubo Y
    Biochem J; 2002 Oct; 367(Pt 1):87-95. PubMed ID: 12084015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X; Huang L; Zhao Y; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. USP11 controls R-loops by regulating senataxin proteostasis.
    Jurga M; Abugable AA; Goldman ASH; El-Khamisy SF
    Nat Commun; 2021 Sep; 12(1):5156. PubMed ID: 34526504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival.
    Liu T; Zhang H; Xiong J; Yi S; Gu L; Zhou M
    Mol Cancer; 2015 Mar; 14():65. PubMed ID: 25888903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deubiquitylation and stabilization of p21 by USP11 is critical for cell-cycle progression and DNA damage responses.
    Deng T; Yan G; Song X; Xie L; Zhou Y; Li J; Hu X; Li Z; Hu J; Zhang Y; Zhang H; Sun Y; Feng P; Wei D; Hu B; Liu J; Tan W; Ye M
    Proc Natl Acad Sci U S A; 2018 May; 115(18):4678-4683. PubMed ID: 29666278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-Wide CRISPR/Cas9-Based Screening for Deubiquitinase Subfamily Identifies Ubiquitin-Specific Protease 11 as a Novel Regulator of Osteogenic Differentiation.
    Kaushal K; Tyagi A; Karapurkar JK; Kim EJ; Tanguturi P; Kim KS; Jung HS; Ramakrishna S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. USP11 degrades KLF4 via its deubiquitinase activity in liver diseases.
    Yang H; Park D; Ryu J; Park T
    J Cell Mol Med; 2021 Jul; 25(14):6976-6987. PubMed ID: 34114341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Regulations of Deubiquitinase USP15 and Its Pathophysiological Mechanisms in Diseases.
    Chou CK; Chang YT; Korinek M; Chen YT; Yang YT; Leu S; Lin IL; Tang CJ; Chiu CC
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.
    Li X; Chen W; Zeng W; Wan C; Duan S; Jiang S
    Br J Cancer; 2017 Jan; 116(1):66-76. PubMed ID: 27875524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
    Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
    Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylated E2F1 is stabilized by nuclear USP11 to drive Peg10 gene expression and activate lung epithelial cells.
    Wang D; Zhao J; Li S; Wei J; Nan L; Mallampalli RK; Weathington NM; Ma H; Zhao Y
    J Mol Cell Biol; 2018 Feb; 10(1):60-73. PubMed ID: 28992046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. USP11 regulates p53 stability by deubiquitinating p53.
    Ke JY; Dai CJ; Wu WL; Gao JH; Xia AJ; Liu GP; Lv KS; Wu CL
    J Zhejiang Univ Sci B; 2014 Dec; 15(12):1032-8. PubMed ID: 25471832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copper-binding properties of the BIR2 and BIR3 domains of the X-linked inhibitor of apoptosis protein.
    Liang Y; Ewing PM; Laursen WJ; Tripp VT; Singh S; Splan KE
    J Inorg Biochem; 2014 Nov; 140():104-10. PubMed ID: 25105866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRL4
    Huang D; Liu C; Sun X; Sun X; Qu Y; Tang Y; Li G; Tong T
    Biochem Biophys Res Commun; 2020 Aug; 529(2):127-132. PubMed ID: 32703400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
    Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
    Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. XIAP: a potential determinant of ovarian follicular fate.
    Phillipps HR; Hurst PR
    Reproduction; 2012 Aug; 144(2):165-76. PubMed ID: 22653317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical detection of antiapoptotic protein X-linked inhibitor of apoptosis in mammary carcinoma.
    Jaffer S; Orta L; Sunkara S; Sabo E; Burstein DE
    Hum Pathol; 2007 Jun; 38(6):864-70. PubMed ID: 17350670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis.
    Zhou S; Huang Q; Zheng S; Lin K; You J; Zhang X
    Tumour Biol; 2016 May; 37(5):6837-45. PubMed ID: 26662313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. XIAP inhibits mature Smac-induced apoptosis by degrading it through ubiquitination in NSCLC.
    Qin S; Yang C; Zhang B; Li X; Sun X; Li G; Zhang J; Xiao G; Gao X; Huang G; Wang P; Ren H
    Int J Oncol; 2016 Oct; 49(4):1289-96. PubMed ID: 27498621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
    Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.